Navigation Links
Ibrutinib Monotherapy Clinical Trial Data in Patients with Waldenstrom's Macroglobulinemia Presented at the International Conference on Malignant Lymphoma in Lugano, Switzerland
Date:6/20/2013

ny is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.  

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements, including our expected liquidity position and timing of the receipt of certain milestone payments, and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "goal", "should", "would", "project", "plan", "predict", "intend", "target" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, expected liquidity or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availabi
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
2. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
3. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
4. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
5. Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma
6. Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
7. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
8. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
9. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
10. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ) today announced ... 28, 2014. Third Quarter Financial Highlights and ... million, reflecting operational growth of 0.5% and a positive ... in the prior year. , Revenues grew in ... revenues grew 3.5%. , GYN Surgical revenues grew ...
(Date:7/30/2014)... July 30, 2014  Cepheid (Nasdaq: ... contract with Premier will end on September 30, ... will be able to continue their relationship with ... MedAssets, Novation, and ROi, in addition to the ... Cepheid. "Cepheid has always recognized and ...
(Date:7/30/2014)... , July 30, 2014 CryoLife, Inc. (NYSE: ... focused on cardiac and vascular surgery, announced today that ... dividend for the third quarter 2014 of $0.03 per ... of $0.03 per share will be paid on September ... of September 12, 2014.  The ex-dividend date for the ...
Breaking Medicine Technology:Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3
...  19, 2011 The Emergency Medicine Patient Safety ... upcoming 1st Annual Patient Safety Summit in Las Vegas, ... Safety in Emergency Care: Excellence in Outcomes, (Twitter ... on solving the patient safety challenges associated with providing ...
... 19, 2011 Medical Care Technologies Inc. ... industry, is pleased to announce that is has signed ... Limited ("OWII"), a private Hong Kong investment holding company ... opening and operating private pediatric clinics throughout China. ...
Cached Medicine Technology:National Leaders in Emergency Medicine and Patient Safety to Address Future Opportunities and Challenges in Emergency Care 2Medical Care Technologies Inc. Signs Letter of Intent for Joint Venture in China 2Medical Care Technologies Inc. Signs Letter of Intent for Joint Venture in China 3
(Date:7/30/2014)... (PRWEB) July 30, 2014 Good ... featured in an upcoming episode of Innovations with ... Discovery Channel. Dates and show times TBA. , ... Good Neighbor Community Services’ vision to redefine the ... individualized and dynamic services. Through passion, innovation, determination, ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July ... States, at least 2,000 Americans die from extreme heat or ... waves, heat stroke or sun stroke caused nearly one-third of ... according to the U.S. Centers for Disease Control and Prevention. ... body heat -- accounted for 63 percent of those weather-related ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 (HealthDay ... excess pounds may want to team up with their child, ... a supervised behavioral modification program gained less weight than their ... average difference of about four pounds over two years). Their ... years, according to the study. "In a nutshell, we ...
(Date:7/30/2014)... happen in an instant: A small child pulls up on ... injured when the furniture tips over. "Every parent or ... and imagine what could tip over, fall off walls and ... a reality," Dr. Alex Rosenau, president of the American College ... Between 2009 and 2011, roughly 43,000 people ended up in ...
(Date:7/30/2014)... Volunteers from the Church of Scientology of Denmark have ... massive distribution of Truth About Drugs education ... Strøget, the famous Copenhagen walking street. Popular with ... ambiance, some quarter of a million people stroll down ... These activities are part of a coordinating effort by ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4Health News:Tip-Over Furniture Can Kill Kids 2
... Research Center Co. announced on Feb. 26 that the ... business cooperation agreement the same day to combine their ... China.SGS-CSTC, a unit of the SGS group, the world,s ... network of over 40 business offices and laboratories in ...
... Executive-level management from biopharma and device sponsors, CROs, consultants, and ... (DIA,s) Realizing Structural Change Management for Patient Recruitment Success Forum ... ... horsham, PA (Vocus) February 26, 2009 -- ...
... this years AmeriGlide Achiever Scholarship. This scholarship is available to full ... ... Raleigh, NC (PRWEB) February 26, 2009 -- AmeriGlide Stair Lifts ... Scholarship. The AmeriGlide Achiever Scholarship is available to full time college ...
... the retina that is responsible for maintaining the health of ... a living retina for the first time. , The ability ... the onset of many diseases of the eye long before ... of Investigative Ophthalmology and Visual Science ., "Our goal ...
... of Putting Money in the Hands of Beauty Corporations for ... or Counseling to Remain Youthful? Now one does not ... Before Published Secrets to Eternal Youth and Immortality, gives FREE ... that folks can attain and maintain the Age they Intend ...
... Goody who will be left behind without a motherHOLLYWOOD, ... "Chani" Christie who recently won the 2009 Martin Luther ... set to donate proceeds from her debut album "My ... Jade Goody. In addition, she also plans to fundraise ...
Cached Medicine News:Health News:QSAI & SGS-CSTC to Begin Joint Food Analysis Services in China 2Health News:DIA to host Patient Recruitment and Retention Forum April 20-21, 2009 2Health News:DIA to host Patient Recruitment and Retention Forum April 20-21, 2009 3Health News:AmeriGlide Announces Recipient of AmeriGlide Achiever Scholarship 2Health News:'Dark cells' of living retina imaged for the first time 2Health News:'Dark cells' of living retina imaged for the first time 3Health News:What the Billion Dollar Beauty Industry Does Not Want Leaked: That One Can Actually Reverse Aging for Free by Moving Only to the Right. We Smell a Nobel. 2Health News:Chantel 'Chani' Christie Will Donate Proceeds From Her Top-Selling Debut Album 'My Dream' to the Children of Terminally Ill TV Star Jade Goody 2
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
... IOL Manipulator (Jaffe-Maltzman), blunt tip, ... end, fits 0.20 mm diameter ... intraocular lenses, (3/bx, 1 bx/ca), ... Sure grip handles hand ridge ...
Sinskey lens manipulator, straight. Also available in titanium....
Straight, with guard. Ideal for multi-directional manipulation....
Medicine Products: